Somatic hypermutation is a specifi c mutagenic process that can diversify the Ig genes at several stages of the B cell diff erentiation pathway: either outside an immune response, leading to repertoire diversifi cation, or during antigen driven responses, leading to affi nity maturation through the selection of B cells displaying better antigen-binding capacities (1) .
Hypermutation is initiated by activationinduced cytidine deaminase (AID) through an enzymatic process that deaminates cytidines into uracils and is essentially, but not exclusively, targeted at the heavy and light chain V genes of the Ig locus (reference 2; for review see references 3, 4). However, mutations at the Ig locus are equally distributed at G/C and A/T bases, which requires that specifi c error-prone repair pathways process this C-focused lesion to broaden its mutation spectrum (5) . In spite of the large number of repair factors able to handle uracils within the eukaryotic cell, only two of them have been shown to contribute to hypermutation: uracil N-glycosylase (UNG) and the DNA-binding moiety of the mismatch repair complex (MSH2-MSH6) (6) (7) (8) (9) (10) (11) (12) (13) (14) . When these two factors are missing, the mutation pattern becomes the imprint of the sole AID action, the replication of uracils generated on both DNA strands resulting in C to T and G to A transitions at the sites of AID deamination (14) .
Error-prone DNA polymerases, in particular those involved in the replicative bypass of DNA lesions, have been considered as prime candidates to generate mutations at A/T base pairs from the initial deamination event. The Ig gene mutation pattern of patients aff ected with the variant form of the xeroderma pigmentosum syndrome, a genetic disease corresponding to inactivation of DNA polymerase η (pol η) (15), was shown to be markedly, albeit We report the complete absence of A/T mutations in MSH2-pol double-defi cient mice, thus indicating that the residual A/T mutagenesis in MSH2-defi cient mice is contributed by pol , now recruited by uracil N-glycosylase, the second DNA repair pathway involved in hypermutation. We propose that this particular recruitment of pol corresponds to a profound modifi cation of the function of uracil glycosylase in the absence of the mismatch repair complex, suggesting that MSH2-MSH6 actively prevent uracil glycosylase from error-free repair during hypermutation. pol thus appears to be the sole contributor of A/T mutations in the normal physiological context. variably, reduced in A/T mutagenesis (16) (17) (18) . Inactivation of pol η in the mouse confi rmed this phenotype and resulted in a more homogeneous reduction in A/T mutations (19) (20) (21) . Similarly, inactivation of the MSH2 protein (or of its MSH6 and exonuclease-1 partners) in the mouse has been shown to result in a decreased mutation load at A/T bases (7-13). These observations have led to a model of hypermutation in which UNG-mediated repair would be responsible for most mutations at G/C bases, whereas the MSH2 pathway would generate the major part of A/T mutations (14) .
But how is the residual A/T mutagenesis observed in both pol η or MSH2-defi cient animals generated? We previously reported that, in Polh −/− mice, the A/T mutation pattern bears the signature of a diff erent enzyme (19) , most probably pol κ, which has an unusual bias toward transversions (22, 23) . The absence of eff ect of pol κ defi ciency on the Ig mutation pattern (24-26) strongly suggested that this enzyme is probably not a normal actor in hypermutation but would rather be recruited only in the absence of the regular polymerase partner. We show in this report that the residual A/T mutagenesis observed in MSH2-defi cient mice is contributed by pol η, now driven by the UNG pathway, thus establishing pol η as the sole polymerase generating A/T mutations during the physiological mutation process. The recruitment of pol η by UNG is discussed in the context of the striking modifi cation of the mutation pattern observed in MSH2-defi cient animals, which leads us to propose a competitive function of mismatch repair that prevents uracil glycosylase from normal, error-free repair.
RESULTS AND D I S C U S S I O N
The residual A/T mutagenesis observed in MSH2-defi cient animals harbors the same overall pattern as the one observed in Ig genes of normal mice, which raises the possibility that it could be generated by pol η, recruited outside the mismatch repair pathway.
We therefore generated Polh −/− Msh2 −/− animals and collected a large mutation database from four to seven mice of the single-or double-defi cient genotypes. We observed rather large interindividual variations in the mutation frequency, notably between two groups of wild-type mice originating from two separate rooms of the same animal facility (Table I and Fig. 1 A) . Taking into account the mutation frequency of the pool of mice constituted by the wild-type littermates of the Polh heterozygous breeding, the mutation frequency was reduced at least two times in either MSH2-or pol η-MSH2-defi cient mice. This reduction is mainly caused by the absence of highly mutated sequences (Fig. 1 C) .
Previous studies have concluded, based on [ 3 H]thymidine incorporation after diff erent mitogenic stimulations, that MSH2 defi ciency did not result in a signifi cant in vitro proliferative defect of splenic B cells, although isotype switching was reduced by two thirds (7, (27) (28) (29) (30) . Using carboxyfl uorescein diacetate succinimidyl ester (CFSE) labeling during in vitro stimulation of splenic B cells with either LPS or LPS plus IL-4, we observed no diff erence in proliferation of pol η-defi cient B cells compared with controls, and only a marginal eff ect of MSH2 defi ciency, which was, however, not manifest in the double Pol η-Msh2 −/− context ( pol η-MSH2-defi cient mice show the same altered distribution of mutation along the Ig sequence as Msh2 −/− mice do, with a striking clustering at a few G/C hotspot positions: seven hotspots concentrate more than half of the mutations in a sequence of 490 bp (Fig. 2) . Most of them (except one, TGTT, at position 38 in the J H 4 intronic sequence, whose targeting is, however, less pronounced in the double-deficient background) correspond to a WGCW sequence, as described previously (W = A or T) (12), with either or both internal G and C bases targeted. One major hotspot present in wild-type mice (AGTT, at position 46) disappears in the absence of MSH2. Similar again to the MSH2-defi cient genotype, a strong increase in transitions within G/C mutations is observed in the double-defi cient context (Table II) .
The main diff erence between MSH2 and pol η-MSH2-defi cient animals resides in A/T mutations: whereas they represent 10% of mutations in Msh2 −/− mice, they are totally absent in the double knockout mice, with the 4 A/T changes collected in a sample of 310 mutations corresponding to the background of the enzyme used for amplifi cation (Fig. 1 B) . It should be noted that the low mutation frequency linked with the MSH2 genetic defect (in the 2 × 10 −3 range) obviously requires high fi delity enzymes to collect mutation samples in which the contribution of the amplifi cation step does not exceed a few percent (2-3% in this experiment, with ‫%06ق‬ of them being As or Ts) (31) . It thus appears that pol η is responsible for the residual A/T mutagenesis observed in MSH2-defi cient animals by being involved in a mutagenic DNA synthesis that now appears to be driven by the UNG pathway. Taking into account our previous data suggesting that, in pol η-defi cient mice, the A/T mutations observed are likely contributed by pol κ recruited in a back-up function, we therefore conclude that, in the normal physiological situation, pol η is the sole polymerase required for A/T mutagenesis at the Ig locus. pol η probably generates some G/C mutations as well, as its mutation spectrum in vitro aff ects G/C bases in a proportion of ‫,%02ق‬ with two thirds of them being transitions and one third being transversions (32) . These numbers fi t remarkably well with the 3% of transversion mutations at G/C positions observed in UNG-defi cient mice (6); indeed, this suggests that 10% of G/C mutations could be generated by pol η via the MSH2 pathway, with one third of them being discernable as transversions in the UNGdefi cient context.
Is the small contribution of pol η via the UNG pathway observed in MSH2-defi cient animals a physiological process? Although this question might not be easily answered, we would like to argue that the overall mutation pattern of MSH2-defi cient animals corresponds to a major alteration of the repair pathways involved, a situation for which, surprisingly, no comprehensive explanation has been brought so far. The seminal work of Rada et al. (14) has shown that the mutation pattern of UNG-MSH2-defi cient animals refl ects the simple footprint of AID deamination and that it is close, in terms of targeting, to the G/C mutation pattern of wildtype animals. It is also quantitatively similar, at least at the V locus, and this striking observation that suggests that both UNG and MSH2 pathways are processing uracils mainly in an error-prone mode. It thus follows that the large decrease in mutation frequency, as well as the increased targeting of specifi c hotspots observed in the MSH2-defi cient background, must be caused by an increased error-free repair of deaminated cytosines by the UNG pathway rather than by 
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modulation of AID targeting by the MSH2-MSH6 complex, as proposed (12, 33) . The mutation hotspots that emerge could correspond to deamination sites at which the residence time of AID would be increased (possibly through their symmetrical WGCW structure that would result in a stronger binding and/or an ineffi cient displacement by the sole UNG enzyme), thus preventing repair at those sites. The AGTT hotspot whose occurrence is restricted to the MSH2-profi cient background would not provide such strong binding and would be more easily repaired. Error-free repair or ignorance would then be the two major outcomes of AID-induced cytidine deamination in the MSH2-defi cient background, resulting in the drop of mutation frequency and the increase in transitions at G/C bases. A small fraction of lesions handled by the UNG pathway would generate abasic sites, leading to transversions when replicated over, or would recruit pol η in an error-prone short patch repair (Fig. 3) .
Collectively, these data emphasize the very dissymmetrical role that the UNG and MSH2 pathways play in the hypermutation process. UNG defi ciency aff ects mainly the nature of G/C mutations, which are biased almost exclusively toward transitions, while having only a moderate impact on the A/T mutagenesis driven by MSH2 (6, 34) and none on the mutation frequency. In contrast, the absence of mismatch repair leads to a stronger modifi cation of the Ig gene mutation pattern, aff ecting not only mutations at A/T bases, as would be expected from a function symmetrical to the one of UNG, but also the overall mutation frequency and, within G/C mutations, the proportion of transitions as well as their distribution along the Ig sequence. Overall, this suggests that, although the function of MSH2-MSH6 is relatively independent from UNG, the mismatch repair complex strongly impinges on the role of UNG during hypermutation by preventing it to perform its natural error-free repair function.
The behavior of UNG in the mismatch repair-defi cient context strikingly mirrors the eff ect of the deliberate overexpression of another uracil glycosylase, SMUG1, in a UNG-MSH2-defi cient background, which results in a major error-free repair accompanied by a smaller error-prone activity generating A/T mutations and G/C transversions (35) .
In conclusion, the exclusive formation of A/T mutations by pol η allows the formulation of a simplifi ed scheme for the role of translesional polymerases in hypermutation (Fig. 3) . pol η would be recruited by the MSH2-MSH6 complex outside of the S phase to permit U/G mismatch recognition, and would mostly generate A/T but also a small amount of G/C mutations in an error-prone short patch repair process that appears thus far restricted to B cells. In contrast, most G/C mutations would be generated by several translesion DNA polymerases (33) (34) (35) (36) (37) (38) , whose exact number remains to be established, acting during replication in their function of lesion bypass by copying abasic sites generated by UNG, which is diverted by MSH2 from its error-free function. In such a model of hypermutation, and in contrast to their physiological repair function, UNG would trigger a translesional process at the replication fork, whereas MSH2-MSH6 would induce a base excision repair outside replication, most probably in the G1 phase of the cell cycle. The involvement of pol η in an error-prone process, whether driven by MSH2 during physiological hypermutation or by uracil glycosylases in specifi c experimental settings, thus appears to be a B cell-specifi c event whose biochemical basis remains to be established. Sequence analysis. B220 + PNA high B cells were isolated from Peyer's patches of 4-6-mo-old animals as previously described (8) . The J H 4 intron fl anking rearranged V H sequences was amplifi ed using a mixture of fi ve V H primers designed to amplify most of the mouse V H families and a downstream primer allowing the determination of 490 bp of noncoding sequences, as reported previously (19) .
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